Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease.

Journal:

Diabetes Care

Published:

2026-01-15

DOI:

10.2337/dc25-0940

Affiliations:

10

Authors:

23

Go to article

Institutions	Authors	Share
Woodruff Health Sciences Center (WHSC), Emory University, United States of America (USA)	19.000000 19.000000	0.83
Emory University, United States of America (USA)	2.000000	0.09
Dr Mohan's Diabetes Specialities Centre, India	1.000000	0.04
All India Institute of Medical Sciences - New Delhi (AIIMS New Delhi), India	1.000000	0.04

Interested in Clinical Sciences?